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Proteins have evolved by incorporating several structural units
within a single polypeptide. As a result, multidomain proteins
constitute a large fraction of all proteomes. Their domains often
fold to their native structures individually and vectorially as each
domain emerges from the ribosome or the protein translocation
channel, leading to the decreased risk of interdomain misfolding.
However, some multidomain proteins fold in the endoplasmic
reticulum (ER) nonvectorially via intermediates with nonnative
disulfide bonds, which were believed to be shuffled to native ones
slowly after synthesis. Yet, the mechanism by which they fold
nonvectorially remains unclear. Using two-dimensional (2D) gel
electrophoresis and a conformation-specific antibody that recog-
nizes a correctly folded domain, we show here that shuffling of
nonnative disulfide bonds to native ones in the most N-terminal
region of LDL receptor (LDLR) started at a specific timing during
synthesis. Deletion analysis identified a region on LDLR that assis-
ted with disulfide shuffling in the upstream domain, thereby pro-
moting its cotranslational folding. Thus, a plasma membrane-
bound multidomain protein has evolved a sequence that promotes
the nonvectorial folding of its upstream domains. These findings
demonstrate that nonvectorial folding of a multidomain protein in
the ER of mammalian cells is more coordinated and elaborated
than previously thought. Thus, our findings alter our current view
of how a multidomain protein folds nonvectorially in the ER of
living cells.
LDL receptor | cotranslational folding | multidomain protein | nonvectorial
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Incorporating several structural domains into a single poly-peptide is a strategy for generating proteins with novel func-
tions in both prokaryote and eukaryote. In eukaryote, more than
two-thirds of all proteins contain multiple domains (1). Their
domains often fold individually and vectorially one after another
as they emerge from the ribosome (2–6). Multidomain proteins
tend to be highly vulnerable to misfolding and aggregation,
probably due to undesired interactions between domains (7–10).
It is generally believed that vectorial folding is preferable for
multidomain proteins as temporal and spatial separation of in-
dividual domains limit the total number of available conforma-
tions, leading to the decreased risk of misfolding (2, 3, 11).
In mammalian cells, approximately one-thirds of the proteins
in the genome will enter the endoplasmic reticulum (ER) for
their folding in this compartment. The folding and activity of
most of these proteins require the formation of proper disulfide
bonds in them (12–15), and failure in the process can lead to
serious disease conditions (14). Thus, understanding the mech-
anisms of disulfide bond formation in these proteins is impor-
tant. The ER of mammalian cells harbors ∼20 protein disulfide
isomerase (PDI) family members that are thought to introduce
disulfide bonds into nascent polypeptide chains (12–14, 16).
However, when and how disulfide bonds form in the chains
remains poorly understood.
A large number of secretory and membrane-bound proteins in
human cells contain not only disulfide bonds but also multiple
domains (13). To decrease the risk of misfolding, their domains
often fold vectorially as their domains appear from the protein
translocation channel (11, 17, 18). However, increasingly, pro-
teins have been identified that likely fold nonvectorially in the
ER via intermediates with nonnative disulfides (19–23) (SI Ap-
pendix, Fig. S1). Yet, how and why their folding proceeds non-
vectorially in the ER remained largely unclear.
Low-density lipoprotein receptor (LDLR) is an intensively
studied plasma membrane-bound multidomain protein contain-
ing three disulfide bonds in each of its seven cysteine-rich do-
mains (R1–R7) and three epidermal growth factor-like domains
(EGF1–EGF3) (Fig. 1A) (24–26). This protein plays a central
role in mammalian cholesterol metabolism by transporting
cholesterol-containing lipoprotein particles from the circulation
into cells. Impaired folding of LDLR can result in hypercholes-
terolemia and increased risk of coronary heart disease, under-
lining the importance of understanding its folding mechanisms
(24–26). Evidence indicates that nonnative disulfides formed at
the early stage of folding are shuffled (isomerized) to native
disulfide bonds (19, 20, 27, 28) through the catalysis of a PDI
family member(s) (12, 27). The shuffling reaction had been
thought to be rate-limiting in the folding pathway (SI Appendix,
Fig. S1), occurring over tens of minutes after synthesis (19, 20).
A similar two-step mechanism is likely adopted by a number of
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proteins (21) including those that obligately require reducing
power for folding (22, 23). However, since these preceding works
studied the behavior of the full-length products, when and how
each step in the folding actually takes place after initiation of
their synthesis remained unclear. Here, we studied the cotrans-
lational folding of LDLR in the ER of living mammalian cells.
We found that disulfide shuffling in an R domain started at a
specific timing during the synthesis of the protein and that a
region downstream of the R domain was responsible for the
disulfide shuffling that occurred cotranslationally. Thus, in con-
trast to the previous view that nonvectorial folding of multido-
main proteins in the ER is a slow process that occurs
posttranslationally (13), it can be highly coordinated and elab-
orated in living mammalian cells.
Results
Observing Disulfide Bond Formation in the Elongating Chains of LDLR.
To investigate the cotranslational folding of LDLR, we inserted
a triple-FLAG tag either at the N terminus of LDLR after the
signal sequence cleavage site (FLAG-LDLR) or after the C
terminus of the protein (LDLR-FLAG) (Fig. 1B) as we have
done before with bacterial alkaline phosphatase (29). Anti-
FLAG antibody can pull down elongating polypeptides from
the former but not the latter construct (29, 30). HeLa cells
expressing these constructs were pulse-labeled for 2 min with
[35S]-methionine and [35S]-cysteine and chased for 20 min in the
absence of radioactivity. To freeze the oxidation status of pro-
teins, we treated cells directly with strong acid and alkylated free
cysteines with N-ethylmaleimide (NEM) (31). The NEM-alkylated
cellular proteins were immunoprecipitated with anti-FLAG anti-
body and analyzed by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS/PAGE) (Fig. 1C). For the N-terminally tag-
ged construct, we observed smeared bands ending at the positions
of LDLR full-length monomer (indicated by an upward arrow on
lane 3). They represent elongating chains of LDLR for the fol-
lowing reasons. First, they were observed when the elongating
chains of LDLR were purified from the N-terminally tagged con-
struct (lane 3), but not when the full-length LDLR was purified
from the C-terminally tagged construct (lane 5). Second, after
20 min of chase, the intensities of these smeared bands became
fainter, with a concomitant increase in the amount of LDLR full-
length monomer (lane 4).
To analyze disulfide bond formation in the elongating chains,
samples were separated by two-dimensional (2D) SDS/PAGE in
which the first dimension was nonreducing and the second re-
ducing (Fig. 2A). On the gels, the distinct electrophoretic mo-
bilities of proteins containing disulfide bonds before and after
reduction cause deviations from the diagonal, allowing analysis
of oxidation status of elongating chains as a function of chain
length: Chains with intramolecular disulfides run on the right of
the diagonal, those with intermolecular disulfides run on the left
(29, 32). Notably, actual detection of the signals corresponding
to the elongating chains of LDLR on 2D gels usually required
the exposure of the imaging plate to the gels of the radiolabeled
proteins for a month or more possibly because of the smallness
of the number of growing chains of a certain chain length (33).
The elongating chains of LDLR were observed as two distinct
populations (Fig. 2A). One population appeared as a continuous
signal along the diagonal, beginning at the smallest detectable
size (<20 kDa) and ending at the size of full-length LDLR (∼140
kDa). The second population of elongating chains appeared as a
distinct and reproducible pattern of streaks to the right of the
diagonal, beginning at the size of 30 kDa and also ending at the
size of full-length LDLR as measured in the reducing dimension.
Because the polypeptides on the latter streaks ran faster under
nonreducing conditions than their reduced forms, they represent
intramolecularly oxidized chains.
Timing of N-Glycosylation and Disulfide Bond Formation in the Elongating
Chains of LDLR.The distribution of radioactivity within the trace of the
oxidized chains of LDLR was uneven (Fig. 2A). While the regions of
high radioactivity generally indicate pause sites in the synthesis of
chains, the regions of low radioactivity correspond to the addition
of N-glycan or a sequence that is translated at a higher rate than the
surrounding codons (18). LDLR is a type I membrane protein con-
taining three Asn residues that are known to receiveN-glycan (Asn156,
Asn272, and Asn657) (34). To study the timing of N-glycosylation at
each residue, we introduced a substitution mutation into them. The
regions of low radioactivity observed at the sizes of ∼35 kDa and
∼60 kDa in the WT LDLR (Fig. 2A) were absent in the LDLR
N156Q and N272Q mutants, respectively (Fig. 2 B and C). They are
therefore likely caused by core glycan addition to Asp156 and Asp272,
respectively.
As we have seen above, disulfide bonds started to form on the
polypeptides when they were elongated to 30 kDa. Importantly,
the polypeptides were already oxidized when they received
N-glycan at Asn156 (Fig. 2 A–D). We used this fact to estimate
the length of polypeptide chains in amino acids at the initiation
of disulfide bond formation as follows. Polypeptide chains en-
tering the ER lumen are often cotranslationally modified with
N-glycan by the oligosaccharyl–transferase complex (OST), an
integral component of the protein translocation machinery (35).
The distance between the ribosome P site and the OST active
site is ∼70 amino acids (11). Therefore, a nascent chain must
have a minimum of ∼70 amino acids after the glycosylation se-
quence for it to receive the N-glycan. Thus, the carboxyl-terminal
residues of the elongating chains at the timing of N-glycosylation
of Asn156 and Asn272 are estimated to be Ser226 and Asp342,
respectively (Fig. 2 E and F). As we have described above, when
the polypeptides received the first N-glycan, they were already
oxidized (Fig. 2 A–D). Thus, disulfide bonds likely started to
Fig. 1. Elongating chains of LDLR purified from cells. (A) Domain organi-
zations of the LDLR. LDLR contains N-terminally located seven cysteine-rich
domains (R1–R7), each stabilized by three disulfide bonds (Upper Right). Two
EGF domains (EGF1 and EGF2) are followed by a six-bladed β-propeller do-
main and a third EGF domain (EGF3). Each EGF domain contains three
disulfide bonds (Lower Right). The regions other than the R and EGF do-
mains do not contain disulfide bonds. Dots, N-glycosylation sites (34);
O-glycosylation, O-glycosylation region; TM, transmembrane domain (19).
(B) Structures of FLAG-tagged LDLR constructs. SS, signal sequence. (C) HeLa
cells expressing the indicated LDLR variants were pulse-labeled for 2 min,
chased for 0 or 20 min, alkylated with NEM, immunoprecipitated with anti-
FLAG antibody, and analyzed by nonreducing SDS/PAGE. Open arrow, the
elongating chains of LDLR.



























form on the polypeptides before their elongation to Ser226
(Fig. 2E).
Whether Asn657 is glycosylated cotranslationally remains un-
clear, as we failed to observe any changes in gel pattern between the
WT and N657Q mutant (Fig. 2 A and D). Furthermore, the region
of low radioactivity reproducibly observed at ∼70 kDa (indicated
by “#” in Figs. 2A and 3A) persisted even when any of the
N-glycosylation sites on LDLR was eliminated (Fig. 2 B–D). Ac-
cordingly, the gap at ∼70 kDa may correspond to a sequence that is
translated at a much higher rate than the surrounding codons.
Notably, such a gap was commonly observed in LDLR variants
(e.g., Fig. 3C and SI Appendix, Fig. S5 A and C; see Fig. 5 A and C)
just before the onset of phase 2 (see below), including an LDLR
variant lacking the third to sixth blades of the β-propeller (SI Ap-
pendix, Fig. S5A). However, since the gap was absent in an LDLR
variant lacking the entire domain (see Fig. 5E), it may be caused by
the N-terminal region of the β-propeller.
Cotranslational Folding of LDLR Is Highly Coordinated and Can Be
Divided into Three Phases. We noticed that the cotranslational
folding of LDLR can be divided into three phases depending on
the steepness of the slopes of oxidized elongating chains ob-
served on the 2D gel (Fig. 3B). On the gel, the greater mobility in
the first dimension is caused by the compactness of the protein
Fig. 2. Disulfide bond formation and N-glycosylation in LDLR analyzed by 2D SDS/PAGE. The elongating chains of LDLR, radiolabeled, and purified from HeLa
cells expressing FLAG-LDLR (A), FLAG-LDLR N156Q (B), FLAG-LDLR N272Q (C), or FLAG-LDLR N657Q (D) were separated by 2D SDS/PAGE and detected by a
phosphorimager. Open arrow, the elongating chains of LDLR; filled arrow, the oxidized elongating chains of LDLR. The regions of low radioactivity observed
at ∼35 and ∼60 kDa on A (see brackets on the oxidized chains) disappeared upon mutating Asn156 and Asn272, respectively (see arrowheads in B and C).
Thus, they correspond to N-glycan addition to Asn156 and Asn272, respectively. #, a region that is likely translated at a much higher rate than the surrounding
codons. (E and F) Estimated topology of ribosome-bound LDLR chains at the timing of N-glycan addition to Asn156 (E) or Asn272 (F). Note that
N-glycosylation requires that the residue that receives N-glycan is located at a minimal distance from the ER membrane of ∼11 amino acids (11). Accordingly,
at the timings of N-glycosylation at Asn156 and Asn272, Cys167 and Lys283 are predicted to be near the luminal side of the ER membrane (E and F). Thus, the
total numbers of cysteine residues exposed to the ER lumen would be 22 and 37, respectively, based on the amino acid sequence of LDLR. As described in
Results, some disulfide bonds were already formed in the elongating chains at the timings of N-glycosylation at Asn156 and Asn272 (E and F). However, we do
not have information on the precise numbers of disulfide bonds formed nor their exact connectivity.


































generated by disulfide bond formation. Thus, the slope slightly
steeper than the diagonal observed during phase 1 suggests that
the growing polypeptides started to form some disulfides when
they were elongated to 30 kDa and continued to form more
disulfides during this phase. When the polypeptides were elongated
to ∼80 kDa, the steep slope was switched with a short gradual slope
of phase 2 that was immediately followed by a moderate slope of
phase 3. During phase 2, the electrophoretic mobility of the poly-
peptides was greatly reduced. The meaning of this event will be
discussed in the next section. Interestingly, deleting the N-terminal
three R domains caused shortening of phase 1 (Fig. 3C). Further
deletion of all R domains caused disappearance of phases 1 and 2,
leaving phase 3 (Fig. 3D). Thus, phases 1 and 2 appear to reflect the
folding reactions of the R domains.
Use of a Conformational Antibody to Observe the Shuffling of Nonnative
Disulfides to Native Ones in the R1 Domain. It is well-established that
the shuffling of nonnative into native disulfide bonds during the
“posttranslational” folding of LDLR is accompanied by a decrease
in the electrophoretic mobility of the protein (19, 20, 27). This fact
led to a model that the protein is first folded into a full-length
compact structure that contains nonnative disulfides between dis-
tant cysteines. During folding, these long loops are substituted by
smaller loops with native disulfides to yield more extended mole-
cules, causing decreased electrophoretic mobility (19). The isom-
erization reaction had occurred over tens of minutes after synthesis
and, thus, had been regarded as a rate-limiting step in the folding
pathway (19, 20, 27).
Interestingly, we observed a similar decrease in the electro-
phoretic mobility of the oxidized elongating chains during phase
2 as described above (Figs. 2A and 3B). It suggests that disulfide
bonds were shuffled at this “specific” timing of protein synthesis.
To examine whether the reaction led to the formation of “na-
tive” disulfide bonds in LDLR, we used anti-LDLR C7 antibody
that recognizes a conformational epitope in the R1 domain
(Fig. 1A), provided that the native disulfide bonds are present,
irrespective of denaturation by SDS (19, 20, 36). We have con-
firmed the properties of the antibody (SI Appendix, Figs. S2 and
S3 and Supplementary Results). The same antibody had been used
to follow posttranslational formation of native disulfide bonds in
LDLR (19, 20). Remarkably, C7 precipitated the oxidized elon-
gating chains only of phase 3 (Fig. 4A), suggesting that the R1
domain acquired correct disulfide bonds near the end of phase 2.
Thus, nonnative disulfide bonds formed in the R domains during
phase 1 were likely isomerized to native ones during phase 2.
Interpretation for the Presence of Both Oxidized and Reduced Elongating
Chains of LDLR within Cells. Analysis of disulfide bond formation in
the elongating chains of LDLR using 2D SDS/PAGE revealed that,
while some of the elongating chains underwent cotranslational ox-
idative folding, the other failed to do so (their signals remained on
the diagonal) (e.g., Figs. 2A and 3A), which tempts us to suspect
that a portion of the elongating chains of LDLR failed to enter the
ER cotranslationally, preventing their cotranslational oxidative
folding. To examine if this could be the case, we looked at the
N-glycosylation of newly synthesized LDLR as the majority of
N-glycosylation sites on human glycoproteins are cotranslationally
modified as they enter the ER lumen (11, 37).
To study the N-glycosylation of newly synthesized LDLR, we
purified the elongating chains of LDLR, treated them with or
Fig. 3. Cotranslational folding of LDLR can be divided into three phases. The elongating chains of LDLR, radiolabeled and purified from cells expressing
FLAG-LDLR (A), FLAG-LDLR ΔR1-R3 (C), or FLAG-LDLR ΔR1-R7 (D), were separated by 2D-SDS/PAGE. In B, the same gel as A was presented for explanation.
Open arrow, the elongating chains of LDLR; filled arrow, the oxidized elongating chains of LDLR. (A) Brackets, the timings of N-glycan addition to Asp156 and
Asn272; parentheses, the presumed C-terminal residue of the polypeptide at the timing of N-glycosylation. (A and C) #, a region that is likely translated at a
much higher rate than the surrounding codons. (B–D) Red arrows, three phases of cotranslational folding.



























without endoglycosidase H (Endo H), and separated them by gel
electrophoresis (SI Appendix, Fig. S4). On this gel, we observed
two bands that correspond to the full-length LDLR. We propose
for the following two reasons that the upper band represents the
N-glycosylated full-length product of LDLR and the lower band
the nonglycosylated full-length product of LDLR that failed to
undergo oxidative folding. First, the digestion of N-glycan by
Endo H converted the upper band to the lower band (SI Ap-
pendix, Fig. S4, lanes 1 and 3), indicating that the upper repre-
sents the N-glycosylated form of LDLR and the lower its
nonglycosylated form. Second, when anti-LDLR C7 antibody
was used to purify LDLR polypeptide that formed native disul-
fide bonds in the R1 domain, the upper band was efficiently
recovered unlike the lower band, indicating that the upper rep-
resents LDLR that had undergone oxidative folding in the ER.
These observations indicate that there are two populations in
the elongating chains of LDLR: those that underwent cotranslational
translocation into the ER and oxidative folding in this compartment,
and those that failed to undergo both N-glycosylation and oxidative
folding cotranslationally. One possible explanation for the lack of
these two modifications would be that the latter population failed to
enter the ER cotranslationally. These findings and consideration can
explain the coexistence of both oxidized and reduced elongating
chains of LDLR within cells.
Phase 2 Starts while the Ribosome Is Translating the β-Propeller Domain.
Phase 2 started when the polypeptide chains were elongated to
∼80 kDa (Fig. 3B). To estimate the position of the carboxyl end of
the growing polypeptide at the beginning of phase 2, we constructed
LDLR mutants each containing a stop codon at the C terminus of
each domain or subdomain (Fig. 4B). A LDLR variant with a stop
codon at the C terminus of the second subdomain (blade) of the
β-propeller yielded a polypeptide chain of ∼80 kDa (Fig. 4C). Thus,
phase 2 likely began when the ribosome was translating the middle
of the β-propeller.
Shuffling of Nonnative Disulfides to Native Ones in the R1 Domain
Requires the β-Propeller Region. Interestingly, deleting some of the
R domains caused phase 2 to start at a shorter chain length (Figs.
3C and 5 A and B). It suggests the presence, in the downstream
region, of a sequence that triggers the onset of phase 2, although
some isolated R domains have been shown to fold properly but
slowly in vitro (38).
To identify a region responsible for the cotranslational shuf-
fling of disulfide bonds, we constructed LDLR variants lacking
various domains. Deleting the EGF1 and EGF2 domains
(Fig. 5 C and D) or the R domains other than R1 (Fig. 5 A and
B) did not inhibit the cotranslational folding of R1, suggesting
the nonessentiality of these domains in the cotranslational
folding of R1. However, interestingly, deleting the β-propeller
domain (Fig. 5 E and F) compromised the cotranslational fold-
ing of R1 as indicated by the disappearance of C7-positive signals
on the oxidized elongating chains (Fig. 5F), demonstrating the
importance of the β-propeller region in shuffling the nonnative
disulfide bonds.
We further analyzed the cotranslational folding of LDLR
lacking the C-terminal two or four blades of the β-propeller to
verify that the entire domain was not essential for the shuffling
but that the cotranslational folding of the upstream domains was
improved progressively as the number of the blade was increased
(SI Appendix, Fig. S5). These findings are consistent with the
present observation that phase 2 started when the ribosome was
translating the middle of the β-propeller (Fig. 4).
Discussion
Many mammalian cell-surface proteins including LDLR adopt
multidomain structures and contain numerous disulfide bonds
(13). Some of these proteins likely fold in the ER nonvectorially
thorough intermediates with nonnative disulfide bonds (19–23).
Shuffling of nonnative disulfide bonds, a key step in their folding,
had been assumed to take place very slowly over tens of minutes
after synthesis (13, 19–21), although it will take only ∼3 min to
synthesize a protein like LDLR (760 amino acid long) given that
the translation rate in mammalian cells is about three to five
amino acids per second (13). Here, we found that the shuffling of
nonnative disulfides in the R1 domain of LDLR takes place at a
specific timing during synthesis, suggesting the presence of a
sequence on LDLR that triggers the shuffling (Fig. 6). This as-
sumption was validated by the discovery of a region on LDLR
(the β-propeller) that was required for the reaction. The sharp-
ness of the signals corresponding to phases 2 and 3 in WT LDLR
(Figs. 2A and 3A) suggests that nonvectorial folding of a multi-
domain protein is a process much more coordinated and syn-
chronized than thought when it occurs during synthesis (Fig. 6).
Fig. 4. Shuffling of nonnative disulfide bonds to native ones starts when
the ribosome is translating the β-propeller region. (A) Cells expressing FLAG-
LDLR were pulsed for 2 min, alkylated with NEM, immunoprecipitated with
anti-LDLR C7 antibody (19), and separated by 2D SDS/PAGE. *, nonspecific
signals (SI Appendix, Fig. S3). Note that anti-LDLR C7 antibody immuno-
precipitated the oxidized elongating chains only of phase 3. (B) Positions of a
stop codon in FLAG-LDLR truncation mutants. (C) The products from the
indicated constructs, prepared as in Fig. 1C, were separated by reducing SDS/
PAGE. Red line, the position of 80 kDa.


































In contrast to the previous model that the disulfide shuffling in
the R1 domain of LDLR is a slow process requiring over tens
of minutes after synthesis, we demonstrated here that it took
place at a much earlier timepoint (that is during synthesis) when
the oxidative folding had started cotranslationally. The merit of
such “cotranslational” shuffling over “posttranslational” one will
be that the domains can reach their native folded structures
more quickly, decreasing the risk of their misfolding. Taking this
advantage into account, we suggest that nonvectorial folding of
some other multidomain proteins in the ER may also proceed
cotranslationally.
Previous works that followed the behavior of newly synthe-
sized full-length LDLR failed to observe that the shuffling of
disulfide bonds in the R1 domain is a highly coordinated process
that takes place at a specific timing during synthesis (19, 20).
This fact underscores the importance of purifying and analyzing
the growing polypeptide chains to discuss cotranslational
oxidative folding process that takes place in cells, although the
experiments are notoriously difficult and it is often required to
expose the imaging plate to the gels of radiolabeled proteins for
a long time (1 mo or more in our studies) to get signals (33).
It is still unclear why folding of some multidomain proteins in
the ER proceeds via intermediates with nonnative disulfide
bonds. One possibility is that some native disulfide bonds cannot
be technically or efficiently introduced into a domain by PDI
family members via a single oxidation reaction, necessitating
prior formation of nonnative disulfide bonds and their sub-
sequent shuffling to native ones (19, 39). In the case of LDLR,
the latter reaction may be somehow assisted by a sequence in the
β-propeller region.
Unlike template-assisted folding in which folding of a domain
is facilitated by its assembly partner (13, 40–42), the β-propeller
and its upstream domains are structurally independent of each
other in the final fold (19, 25, 26). Thus, some multidomain
Fig. 5. The β-propeller region is required for the efficient cotranslational folding of LDLR. NEM-treated cell lysates, prepared as in Fig. 1C from cells
expressing FLAG-LDLR ΔR2-R7 (A and B), FLAG-LDLR ΔEGF1-EGF2 (C and D), or LDLR Δβ-propeller (E and F), were immunoprecipitated with anti-FLAG (A, C,
and E), or anti-LDLR C7 antibody (B, D, and F) and separated by 2D SDS/PAGE. Note that anti-LDLR C7 antibody immunoprecipitated the oxidized elongating
chains only of phase 3 in B and D. Open arrow, the elongating chains of LDLR; closed arrow, the oxidized elongating chains of LDLR. Red arrows, three phases
of cotranslational folding. #, a region that is likely translated at a much higher rate than the surrounding codons. *, nonspecific signals. Note also that
nonspecific signals are less evident in F (see also SI Appendix, Fig. S3 legend).



























proteins may have evolved a sequence that can temporally assist
in the folding of its structurally unrelated upstream domains.
Further analysis on the identity of the nonnative disulfide
bonds that form during productive folding and the role of the
downstream region in the shuffling reaction will help us define
the principle for the nonvectorial folding of proteins in the ER of
mammalian cells.
Materials and Methods
Plasmids. Plasmids used in this study are listed in SI Appendix, Table S1.
Procedures for the construction of plasmids are described in SI Appendix,
Supplementary Materials and Methods.
Cell Culture, Transfection, Pulse-Chase, and Alkylation. HeLa cells were main-
tained in Dulbecco’s modified Eagle’s medium (DMEM) (catalog no. 08458;
Nacalai Tesque) supplemented with 10% fetal bovine serum (FBS) at 37 °C in
5% CO2 air.
For transfection, HeLa cells were often plated onto a 6-cm dishes at 5 × 105
cells per dish, cultured for 24 h, and transfected with 3 μg of DNA using
Lipofectamine LTX (Invitrogen), following manufacturer’s instruction. At
24 h after transfection, cells were incubated in 1.5 mL per dish of depletion
medium (Gibco Met-free, Cys-free DMEM supplemented with 2 mM L-glu-
tamine, 1 mM sodium pyruvate, and 5% dialyzed FBS) for 30 min and pulse-
labeled with 55 μCi/mL of EasyTag EXPRESS35S Protein Labeling Mix (Per-
kinElmer) for 2 min. When chase was conducted, cells were washed with
phosphate-buffered saline (PBS) and then incubated in 1.5 mL of chase
medium (DMEM supplemented with 10% FBS, 5 mM L-methionine, and
5 mM L-cysteine) to initiate the chase period. Following pulse or chase, cells were
washed twice with PBS, directly treated with 1 mL of ice-cold 10% trichloroacetic
acid, and collected in a tube. After 20-min incubation on ice, proteins were
collected by centrifugation and washed twice with ice-cold acetone to remove
acid. Free cysteines in the sample were then alkylated with NEM using NEM
alkylation buffer (100mM Tris·HCl [pH 6.8], 2% SDS, 50 mMNEM) supplemented
with 2 μg/mL pepstatin A, 1 mM benzamidine, and 1 mM phenylmethylsufony
fluoride (PMSF) essentially as described before (43).
Antibodies. Mouse anti-FLAG M2 and anti-LDLR C7 antibodies were pur-
chased from Sigma-Aldrich and Santa Cruz Biotechnology, respectively.
Rabbit monoclonal anti-LDLR EP1553Y antibody that recognizes the C ter-
minus of LDLR was obtained from Abcam.
Immunoprecipitation. To purify LDLR polypeptides fused with a triple FLAG
tag, 150 μg of NEM-treated HeLa cell lysate (see above) was diluted 10-fold
with ice-cold KI buffer (2% [wt/vol] Triton X-100, 50 mM Tris·HCl [pH 8.0],
150 mM NaCl, 1 mM EDTA) and centrifuged at 15,000 × g for 10 min at 4 °C
to obtain NEM-treated cleared cell lysate. To purify LDLR polypeptides
containing the triple FLAG tag from the cleared cell lysate, mouse anti-FLAG
M2 antibody was bound to Surebeads protein G magnetic beads (Bio-Rad) in
the presence of ice-cold KI buffer following the supplier’s instructions. The
resulting beads were incubated with the NEM-treated cleared cell lysate for
3 h at 4 °C. The immune complexes were collected by magnetization and
washed four times with 800 μL of ice-cold High Salt buffer (1% [wt/vol]
Triton X-100, 50 mM Tris·HCl [pH 8.0], 1 M NaCl, 1 mM EDTA), and once with
800 μL of 10 mM Tris·HCl (pH 8.0). The immunoisolates were then released by
incubating the sample at 37 °C for 1 h with 65 μL of 2× Laemmli sample
buffer supplemented with 10 mM NEM, 2 μg/mL pepstatin A, 1 mM ben-
zamidine, and 1 mM PMSF.
To purify LDLR polypeptides that have acquired correct disulfide bonds in
the R1 domain, 300 μg of NEM-treated HeLa cell lysate (see above) was di-
luted 10-fold with ice-cold KI buffer containing 2 mM CaCl2 and then
centrifuged at 15,000 × g for 10 min at 4 °C to obtain NEM-treated cleared
cell lysate. LDLR polypeptides that have acquired correct disulfide bonds in
the R1 domain were then purified from the cleared lysate using anti-LDLR C7
antibody bound to Surebeads protein A magnetic beads (Bio-Rad) essentially
as described above except that the immune complexes were washed six
times with ice-cold High Salt buffer and once with 10 mM Tris·HCl (pH 8.0)
before releasing the immunoisolates.
Nonreducing, Reducing 2D Gel Electrophoresis. Ten microliters of immuno-
precipites from the pulsed samples were separated on a nonreducing 10%
SDS/PAGE. The gel lanes were cut off, incubated in gel reducing buffer
(75 mM Tris·HCl [pH 6.8], 2% [wt/vo] SDS, 15% [wt/vol] glycerol, 5% [vol/vol]
β-mercaptoethanol, and 10 μg/mL bromophenol blue) at 80 °C for 10 min.
The proteins in the gel were then separated on a 2D gel, dried on a filter
paper, and detected by an imaging plate, BAS IP MS 2040 E (GE Healthcare)
and a PhosphorImager FLA-2000 (Fuji Film). To observe changes in the oxi-
dation states of the elongating chains of LDLR on the 2D gel, we exposed
the imaging plate to the dried gels from 1 to 3 mo. We added 5 μL of Novex
Sharp Prestained Protein Standard (Thermo Fisher Scientific) to the immu-
noprecipitates just before running the 1D gel to confirm the proper protein
separation on a 2D gel. If separated properly, the marker proteins will mi-
grate on a diagonal as sharp spots on the 2D gel. Otherwise, we repeated
the gel electrophoresis. We used Novex Sharp Prestained Protein Standard
(Thermo Fisher Scientific), as maker proteins for gel electrophoresis as re-
ductant is not added to its loading buffer and, thus, this reagent does not
perturb the migration of oxidized proteins in adjacent lanes.
Data Availability. All data and associated protocols are available in the main
text and SI Appendix.
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Fig. 6. Model for the cotranslational folding of LDLR. Note that the number and connectivity of nonnative disulfide bonds that form during phase 1
are unknown.
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